✦ LIBER ✦

Importance of cytochrome P450 (CYP450) in adverse drug reactions due to drug–drug interactions: a PharmacoVigilance study in France

✍ Scribed by Danton, Anne Charlotte; Montastruc, François; Sommet, Agnès; Durrieu, Geneviève; Bagheri, Haleh; Bondon-Guitton, Emmanuelle; Lapeyre-Mestre, Maryse; Montastruc, Jean-Louis

Book ID: 115488827
Publisher: Springer
Year: 2012
Tongue: English
Weight: 119 KB
Volume: 69
Category: Article
ISSN: 0031-6970
DOI: 10.1007/s00228-012-1394-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The importance of drug–drug interactions

The importance of drug–drug interactions as a cause of adverse drug reactions: a pharmacovigilance study of serotoninergic reuptake inhibitors in France

✍ Francois Montastruc; Agnès Sommet; Emmanuelle Bondon-Guitton; Geneviève Durrieu; 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 181 KB

Adverse drug reactions related to drugs

Adverse drug reactions related to drugs used in orthostatic hypotension: a prospective and systematic pharmacovigilance study in France

✍ Atul Pathak; Valérie Raoul; Jean-Louis Montastruc; Jean-Michel Senard 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 187 KB

No evidence of increased adverse drug re

No evidence of increased adverse drug reactions in cytochrome P450 CYP2D6 poor metabolizers treated with fluoxetine or nortriptyline

✍ Rebecca L. Roberts; Roger T. Mulder; Peter R. Joyce; Suzanne E. Luty; Martin A. 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 75 KB

## Abstract The polymorphic enzyme cytochrome P450 CYP2D6 is involved in the metabolism of many antidepressants, including nortriptyline and fluoxetine. Some 7%–10% Caucasians have inactivating mutations in both alleles of the __CYP2D6__ gene, and are referred to as poor metabolizers (PMs). Several

In Vitro Assessment of Metabolic Drug-Dr

In Vitro Assessment of Metabolic Drug-Drug Interaction Potential of Apixaban through Cytochrome P450 Phenotyping, Inhibition, and Induction Studies

✍ Wang, L.; Zhang, D.; Raghavan, N.; Yao, M.; Ma, L.; Frost, C. A.; Maxwell, B. D. 📂 Article 📅 2009 🏛 American Society for Pharmacology and Experimental 🌐 English ⚖ 444 KB

Re: no evidence of increased adverse dru

Re: no evidence of increased adverse drug reactions in cytochrome P450 CYP2D6 poor metabolizers treated with fluoxetine or nortriptyline

✍ P. K. Gillman 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 38 KB

Development of an in vitro drug–drug int

Development of an in vitro drug–drug interaction assay to simultaneously monitor five cytochrome P450 isoforms and performance assessment using drug library compounds

✍ Michael Zientek; Howard Miller; Danielle Smith; Mary Beth Dunklee; Lance Heinle; 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 896 KB